Concepedia

Efficacy of an Ondansetron Orally Disintegrating Tablet: A Novel Oral Formulation of this 5-HT3 Receptor Antagonist in the Treatment of Fractionated Radiotherapy-Induced Nausea and Emesis

J. P. Lebourgeois, Charles J. McKenna, B. Coster, Petra Feyer, Lars Franzén, L. Goedhals, Z Marzecki, Luís Souhami, Alan L. Stewart, F. Tønnessen,

Clinical Oncology · 1999 · 48 citations · 10 references

DOI

Concepts

References

10

The effect of a susceptibility to motion sickness on the side effects of cancer chemotherapy

Gary R. Morrow · Cancer · 1985 · 104 citations · Full text

, , +12

Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study

C. Seynaeve, Jan C. Schuller, K. Buser et al. · British Journal of Cancer · 1992 · 102 citations · Full text

, , +16

Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation

T.J. Priestman, J.T. Roberts, H.H. Lucraft et al. · Clinical Oncology · 1990 · 91 citations

, , +14

Efficacy of Oral Ondansetron in the Prevention of Emesis in Outpatients Receiving Cyclophosphamide-based Chemotherapy

Thomas Beck · Annals of Internal Medicine · 1993 · 88 citations

, , +15

Ondansetron Compared with Metoclopramide in the Control of Emesis and Quality of Life during Repeated Chemotherapy for Breast Cancer

M. Soukop, B. McQuade, E Hunter et al. · Oncology · 2009 · 88 citations

, , +17